Informed Consent

N Engl J Med 2017; 376:856-867
Authors: Jeffrey M. Drazen, David P. Harrington, et al
“In the classic interaction in which informed consent is obtained for research, an investigator presents the potential participant with information regarding a new therapeutic, diagnostic, or prophylactic intervention and then asks the participant to read and sign a detailed written consent document. This traditional prototype is becoming outdated. Informed consent, which is ethically essential in most clinical research, respects persons’ rights to decide whether participation in the research is compatible with their interests, including their interests in protection from exploitation and harm. Required by ethical guidelines and regulations unless explicitly waived by institutional review boards, informed consent is thus a means of protecting the rights and welfare of participants while they contribute to the advancement of knowledge.”
Find article here.

Health incentive research and social justice: does the risk of long term harms to systematically disadvantaged groups bear consideration?

Journal of Medical Ethics 2017;43:150-156.
Authors: Wild V, Pratt B
“The ethics of health incentive research—a form of public health research—are not well developed, and concerns of justice have been least examined. In this paper, we explore what potential long term harms in relation to justice may occur as a result of such research and whether they should be considered as part of its ethical evaluation.”
Find article here.

Monash University defends greyhound killing, says research needed for heart transplants

SMH, 12 September 2016
Author: Broede Carmody
“Monash University has defended killing greyhounds in the name of science, arguing an experiment where dogs had their hearts removed and new ones inserted before being euthanased will have a “valuable influence” on the thousands of people around the world in need of a heart transplant.”
Find article here.

Sugar Industry Quashed Findings Linking Sugar To Heart Disease Over 50 Years Ago, Says Report

Forbes, 12 September 2016
Author: Nancy Fink Huehnergarth
“A startling new report published today in JAMA Internal Medicine found that more than 50 years ago, sugar industry-funded and guided research successfully suppressed findings linking sugar intake to an increased risk of heart disease. The influential 1967 literature review, written by prominent nutrition researchers at the Harvard School of Public Health and published in the prestigious New England Journal of Medicine, determined that dietary cholesterol and saturated fat were risk factors for cardiovascular disease (CVD), while criticizing studies that linked sugar to CVD.”
Find article here.

‘I’ve been paid by drug companies and I don’t believe I’ve done anything wrong’

SMH, 12 September 2016
Author: Tom John
“We are treating real people with life-threatening illnesses and the sense of urgency is palpable. My international colleagues also talk of begging companies for access to the next drug, which is only possible through an existing relationship. So while it is easy to add up the dollars and tarnish medical practitioners for engaging with the pharmaceutical industry, it is important to consider why many of us do so. Transparency is important, but so is the access it provides to cutting-edge treatments in a timely way.”
Find article here.